Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Hemiparesis, Hypoaesthesia, Limb discomfort, Muscular weakness, SARS-CoV-2 test
Clinical narrative: 26Oct2020- covid test positive - no Covid symptoms -quarantined 2 weeks; 26Oct2020- covid test positive - no Covid symptoms -quarantined 2 weeks; stroke symptoms; Left side numbness and weakness; Legs feeling weak and heavy; difficulty ambulating; Legs feeling weak and heavy; GB syndrome Post Vaccine; Finger Numbness/Numbness on L side of face and head/Left side numbness and weakness; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from product quality group.  A 46 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administration date 04Mar2021 (Lot number: EN6199) at the age of 46 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "covid" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: GUILLAIN-BARRE SYNDROME (hospitalization, disability, medically significant) with onset 06Mar2021, outcome "not recovered", described as "GB syndrome Post Vaccine"; CEREBROVASCULAR ACCIDENT (hospitalization, disability, medically significant) with onset 09Nov2021, outcome "not recovered", described as "stroke symptoms"; HEMIPARESIS (hospitalization, disability, medically significant) with onset Nov2021, outcome "not recovered", described as "Left side numbness and weakness"; LIMB DISCOMFORT (hospitalization, disability), MUSCULAR WEAKNESS (hospitalization, disability) all with onset Nov2021, outcome "not recovered" and all described as "Legs feeling weak and heavy"; COVID-19 (hospitalization, disability), DRUG INEFFECTIVE (hospitalization, disability, medically significant), outcome "not recovered" and all described as "26Oct2020- covid test positive - no Covid symptoms -quarantined 2 weeks"; HYPOAESTHESIA (hospitalization, disability) with onset 04Mar2021, outcome "not recovered", described as "Finger Numbness/Numbness on L side of face and head/Left side numbness and weakness"; GAIT DISTURBANCE (hospitalization, disability) with onset Nov2021, outcome "not recovered", described as "difficulty ambulating". The patient was hospitalized for guillain-barre syndrome, cerebrovascular accident, hemiparesis, limb discomfort, covid-19, drug ineffective, hypoaesthesia, gait disturbance, muscular weakness (hospitalization duration: 6 day(s)). The events "gb syndrome post vaccine", "stroke symptoms", "left side numbness and weakness", "legs feeling weak and heavy", "26oct2020- covid test positive - no covid symptoms -quarantined 2 weeks", "26oct2020- covid test positive - no covid symptoms -quarantined 2 weeks", "finger numbness/numbness on l side of face and head/left side numbness and weakness", "difficulty ambulating" and "legs feeling weak and heavy" were evaluated at the physician office visit and emergency room visit. The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (02Mar2021) negative; (26Oct2021) positive. Therapeutic measures were taken as a result of hemiparesis, limb discomfort, gait disturbance, muscular weakness. Clinical course: 21Nov2021-ER 21Nov-27Nov2021 hospital Left side numbness and weakness Legs feeling weak and heavy, difficulty ambulating, dragging legs Numbness on L side of face and head 5 days of IVIG I did not work 5 months 16 doses IVIG 09Nov2021 ER and 1 day in the Hospital Numbers on the L side of the face, difficulty ambulating , stroke symptoms 21Nov-27Nov2021 hospital.